Novolight DX

Hematological Analysis Devices

Health Tech & Life Sciences
Stealth Mode
Seed Tel Aviv-Yafo, Israel Founded 2023
Last updated 2026-06-18
Total raised
Last: 2024-01
Stage
Seed
Founded
2023
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

This company is a known business entity but lacks sufficient data to support a standard Finder profile.

Funding history · 1 round · — total

Q&A

What is the current status of Novolight DX?
Novolight DX is currently inactive, having ceased operations in August 2025.
When was Novolight DX founded?
Novolight DX was founded in June 2023.
What is the primary sector of Novolight DX?
Novolight DX operates in the Health Tech & Life Sciences sector, focusing on Medical Devices and Diagnostics Devices.
How many employees does Novolight DX have?
Novolight DX has 1-10 employees.
What type of products does Novolight DX develop?
Novolight DX develops hematological analysis devices.
Which investors participated in Novolight DX's funding round in January 2024?
In January 2024, Novolight DX received funding from Israel Innovation Authority.
What is the current product stage of Novolight DX?
Novolight DX's product is currently in the R&D stage.

Team · 2

Founder · Co-Founder & CEO
LinkedIn ↗
Founder · Co Founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B

Tags

stealthmodeblood-testhematology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2023-6
Employees (exact)5
Status reasonNon Active, Aug 2025 ceased to operate